Company Profiles

driven by the PitchBook Platform

AMP Therapeutics

AMP Therapeutics
2009 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Operator of a pharmaceutical company developing anti-microbial peptides. The company focuses on the discovery and development of antibiotics for the treatment of multi drug-resistant Gram-negative infections.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
Deutscher Platz 5c
04103 Leipzig
Germany

+49 (0)34 1350 5599 0
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AMP Therapeutics’s full profile, request a free trial.

AMP Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Nov-2016 Completed Generating Revenue
2. Grant 25-Oct-2012 00.00 Completed Startup
1. Early Stage VC (Series A) 05-Jan-2012 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

AMP Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Jörg Gabert Co-Founder, Vice Chairman of the Advisory Board and Managing Director
Marc Hentz Managing Director, Finance and Business Development
Knut Adermann Scientific Director
Ralf Hoffmann Ph.D Co-Founder (Scienific)
Bernrd Eisele Advisor

You’re viewing 5 of 5 executives.

AMP Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Jörg Gabert AMP Therapeutics Co-Founder, Vice Chairman of the Advisory Board and Managing Director 000 0000

1 Former Board Members

You’re viewing 1 of 1 board members.